Evidence map›Paper›PMID 40848259›Full record

Trial reportEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2025

Conduction system pacing vs. biventricular pacing for cardiac resynchronization: the CSP-SYNC randomized single centre study.

David Žižek, Tadej Žlahtič, Miha Mrak, Maja Ivanovski, Jernej Štublar, Dinko Zavrl Džananović, Jakob Peterlin, Marta Cvijić, Anja Zupan Mežnar

Abstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Conduction system vs. biventricular pacing in heart failure with reduced ejection fraction: a meta-analysis of randomized controlled trials.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Pooled it
  2. Conduction system pacing vs. biventricular pacing for cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis considering randomized controlled trials and observational studies.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Pooled it
  3. Conduction system pacing for cardiac resynchronization therapy: a systematic review.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Review
  9. Electromechanical window as an integrative marker of remodeling and arrhythmic risk in biventricular vs. left bundle branch area pacing.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026
    Article
  10. Conduction system pacing: what emerging evidence and what indications?Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Review
  11. Article
  12. Observational
  13. Article
  14. Review
  15. Review
  16. Review
  17. Controversy: in heart failure patients with a reduced ejection fraction and left bundle branch block, conduction system pacing can be a valid alternative to biventricular pacing-pro and contra.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David ŽižekCardiology Department, University Medical Centre Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia.ORCID 0000-0001-5029-3989
Tadej ŽlahtičCardiology Department, University Medical Centre Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia.ORCID 0000-0002-4014-5680
Miha MrakCardiology Department, University Medical Centre Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia.ORCID 0000-0002-6258-6401
Maja IvanovskiCardiology Department, University Medical Centre Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia.ORCID 0009-0003-0189-099X
Jernej ŠtublarCardiology Department, University Medical Centre Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia.
Dinko Zavrl DžananovićCardiology Department, University Medical Centre Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia.ORCID 0000-0001-9520-5575
Jakob PeterlinFaculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.ORCID 0009-0006-0437-946X
Marta CvijićCardiology Department, University Medical Centre Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia.ORCID 0000-0003-2166-7720
Anja Zupan MežnarCardiology Department, University Medical Centre Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia.ORCID 0000-0003-3650-5986

Funding

Slovenian Research and Innovation Agency P03-456Slovenian Research and Innovation Agency P3-0154University Medical Centre Ljubljana
6 · The paper itself

Abstract

aimsThere are limited prospective randomized studies comparing left bundle branch area pacing (LBBAP) and biventricular (BiV) pacing for cardiac resynchronization therapy (CRT). The study tested whether LBBAP is non-inferior to BiV pacing in patients with Class I indication for CRT. METHODS AND

resultsThe CSP-SYNC study is an investigator-initiated, randomized, single-centre study. Sixty-two patients were randomized 1:1 to LBBAP or BiV. The primary study endpoint was the change in left ventricular ejection fraction (LVEF) at 6 months. Secondary endpoints included changes in echo and clinical parameters after 6 months and 12 months. Thirty-one patients were randomized to each arm. Most patients were males (71%), and 32% had ischaemic cardiomyopathy. At 6 months, similar improvement of LVEF was observed in the LBBAP group compared to the BiV group [14.0% (95% confidence interval (CI): 11.2-16.8) in LBBAP vs. 8.5% (95% CI: 5.6-11.2) in BiV] with a mean intergroup difference of 5.6% (95% CI: 1.6-9.5; P < 0.001 for non-inferiority). Both groups showed comparable decrease in LVESV [-64 mL (95% CI: -78 to -50) vs. -40 mL (95% CI: -54 to -25) respectively, mean difference -24 mL (CI 95%: -44 to -4); P < 0.001 for non-inferiority] and changes in 6-min walk test (P < 0.001 for non-inferiority) and NYHA class (P = 0.011 for non-inferiority). Temporal trends of LV remodelling and heart failure hospitalization rates were also comparable.

conclusionIn patients with a Class I indication for CRT, LBBAP was non-inferior to BiV pacing in improving LVEF and provided similar structural and electrical remodelling.

Indexed as

Bundle of HisCardiac Resynchronization TherapyHeart FailureAgedFemaleHumansMaleMiddle AgedProspective StudiesRecovery of FunctionStroke VolumeTime FactorsTreatment OutcomeVentricular Function, LeftVentricular RemodelingBiventricular pacingCardiac resynchronization therapyConduction system pacingLeft bundle branch area pacingLeft bundle branch block

Identifiers

PMID40848259
PMCPMC13223735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.